Berkshire Hathaway: The Cash Hoard Era Is Over, and That Changes the Valuation Case

Berkshire Hathaway reported second-quarter 2026 operating earnings of $12.98 billion, up 16%, while net income surged 107% to $25.67 billion on a $10.9 billion investment gain. The headline numbers are clean. The story underneath them is structural: under CEO Greg Abel, who succeeded Warren Buffett in January 2026, Berkshire has ended a 14-quarter pattern of net stock selling, deployed nearly $20 billion in net equity purchases, spent $4.5 billion on share buybacks, acquired homebuilder Taylor Morrison for $6.8 billion, and invested $10 billion in Alphabet.

The cash pile — $397.4 billion at the end of March — fell to $365.5 billion by June. That is the first sequential decline in four years. It matters because Berkshire's previous strategy of sitting on a mountain of cash was effectively a bet that markets would become cheaper. Abel is signaling that he considers the current landscape offer enough to start deploying, even if the broader market is expensive.

The valuation gap that has made Berkshire an attractive retirement holding — the stock trades at 13.1 times trailing earnings and 1.5 times book value — remains intact. But the question now shifts from whether Berkshire will ever deploy this cash to how aggressively it is doing so, and whether the first moves under Abel justify continued confidence.

The Operating Business: Steady, Not Spectacular

Operating earnings — the measure of ongoing business performance, stripped of investment gains and losses — rose 16% to $12.98 billion from $11.16 billion in Q2 2025. That growth was unevenly distributed across Berkshire's divisions, and the breakdown tells the real story.

The manufacturing, service, and retailing segment, which includes companies from Precision Castparts to Duracell, delivered the best result with operating profit up 24% to $4.47 billion on revenue that grew 15% year-over-year to $61.5 billion. Berkshire Hathaway Energy, the utilities arm, saw profit surge 27% to $891 million. BNSF Railroad grew earnings 6% to $1.56 billion on operating revenue that added $6.6 billion.

Insurance — historically Berkshire's profit engine — was the weak link. Underwriting earnings fell 13% to $1.73 billion, weighed down by results from Geico. Insurance investment income also declined 9% to $3.06 billion, reflecting the shifting rate environment and portfolio rebalancing. Insurance float (the net liabilities assumed under insurance contracts, essentially free or low-cost capital that policyholders provide while claims are outstanding) stood at $177.5 billion at quarter end, an increase that keeps the funding pool intact even as underwriting profitability softens.

So what do these segment results mean? The operating businesses are growing, but not at a rate that alone justifies bullish enthusiasm. The 16% operating earnings growth is solid for a $1.12 trillion conglomerate, but insurance underwriting is trending in the wrong direction. Buffett himself has long told investors to focus on operating earnings over net income, precisely because the latter swings wildly with unrealized investment gains and losses — accounting rule changes in 2018 forced those swings onto the income statement. By that Buffett-endorsed measure, the quarter was good but not transformative.

The Capital Deployment Pivot

This is where the Q2 results become interesting from a valuation perspective. For more than three years, Berkshire was a net seller of equities, trimming holdings and accumulating cash while waiting for a better entry point. That pattern broke decisively in Q2 2026.

The company repurchased approximately $4.5 billion in shares during May and June, buying back 478 Class A shares and more than 8 million Class B shares. That is a dramatic acceleration from the $234 million spent on buybacks in the first quarter, when Abel had only just resumed repurchases after a two-year hiatus starting in 2024. The Q2 spend also came in at the low end of investor expectations, which had ranged between $5 billion and $11 billion based on a July SEC filing that disclosed the planned buyback band.

Berkshire became a net buyer of equities with nearly $20 billion in net stock purchases ($23.5 billion bought versus $3.7 billion sold), the first time since 2023 that purchases exceeded sales. The Alphabet investment — $10 billion deployed in June — pushed the tech company into Berkshire's five largest equity holdings alongside Apple, American Express, Bank of America, and Coca-Cola. Buffett said he began the Alphabet investment after consulting with Abel, which suggests continuity rather than a radical break from the prior investment philosophy.

The Taylor Morrison acquisition closed in July 2026, after the Q2 reporting period, so it does not appear in the quarterly figures. OxyChem, the $9.7 billion chemicals division spun out of Occidental Petroleum, also closed during the quarter. Both deals signal Abel's willingness to make large, definitive acquisitions rather than waiting for distress.

The implication for investors is straightforward: the era of cash accumulation as Berkshire's default posture appears to be ending. Whether $365.5 billion is still "too much" cash or just the right amount of dry powder depends on your view of market valuations. Abel's approach — deploying capital where the reward matches the risk, as he framed it at the May 2026 annual meeting — suggests a more measured, selective pattern rather than rapid fire.

What the Balance Sheet Actually Supports

Berkshire's capital structure is the kind of fortress that makes the valuation gap hard to close. Total debt stands at $512.9 billion against total equity of $750.2 billion, a debt-to-equity ratio of 17.1%. The company generated $46.6 billion in operating cash flow over the trailing twelve months, with capital expenditures of $22.4 billion, implying free cash flow of roughly $24.2 billion. On that basis, net debt is approximately $128.6 billion — a manageable burden for a company generating this much cash.

The key question for a value investor is whether the current valuation already reflects the cash on the balance sheet, or whether the market is still underpricing the optionality that $365.5 billion in cash and treasuries provides. Berkshire trades at a price-to-book ratio of 1.5, which is near the upper end of its historical range but still below many diversified industrial peers. For context, GE Aerospace trades at 42.8 times earnings and 21.5 times book; 3M trades at 31.5 times earnings and 31.4 times book; Union Pacific trades at 23.8 times earnings and 8.4 times book. Berkshire's 13.1-times-earnings multiple looks cheap by comparison — but conglomerates like Berkshire are always discounted because their value is harder to model and their parts are worth more than the sum of how the market prices the whole.

The PEG ratio of 0.36 (price-to-earnings-growth) reinforces the valuation gap: the market is not charging for the 10.4% revenue growth that Berkshire delivered year-over-year, even though the growth came from a very large base. Return on equity at 12.1% is respectable for a diversified holding company, though the negative ROIC figure reported by some data sources reflects Berkshire's massive cash holdings dragging down the return on invested capital metric — a quirk of the model, not a sign of poor capital allocation.

The Valuation Gap and the Retirement Portfolio Role

The central tension in the Berkshire story right now is not earnings growth or buyback volume. It's whether the stock at $780,000 per Class A share — near its 52-week high of $788,300, up 3.4% year-to-date and 11.5% on a rolling annual basis — still offers attractive value for a long-term holder.

Three observations frame the answer. First, Berkshire has underperformed the S&P 500 this year (up 3% versus the index's 13%), despite strong operating results. That lag is a function of the stock's large cash drag — billions of dollars sitting in cash earn less than the broad equity market — and the conglomerate discount that always applies. As cash gets deployed into equities and acquisitions, that drag should gradually lessen.

Second, the buyback acceleration matters for per-share value even though Berkshire pays no dividend. Repurchases are functionally equivalent to a return of capital, concentrating the ownership stake in the remaining shares. At current prices, the $4.5 billion spent in Q2 represents a small but meaningful annual run rate if sustained. Abel and Buffett have historically stated that buybacks occur only when they believe shares are trading below intrinsic value — which is skin in the game that validates the valuation case.

Third, the insurance underwriting headwind is real but not existential. Underwriting earnings fell 13%, but float grew and the investment income decline (9%) is a rate-driven issue that should normalize. The insurance franchise remains the structural advantage that allows Berkshire to invest other people's money at scale.

For a retirement portfolio, Berkshire serves a compounding role rather than an income role — there is no dividend, so it generates no current yield. Its value lies in the durable moats of its owned businesses (insurance distribution, rail infrastructure, energy assets), the pricing power embedded in its retail and industrial subsidiaries, and the optionality of its investment portfolio. At 13 times earnings and 1.5 times book, with a PEG ratio well below 1.0, the entry point still has room.

Rating: Buy. The 16% operating earnings growth confirms the operating businesses remain resilient. The capital deployment pivot under Abel removes the lingering question of whether Berkshire's cash would ever be put to work. The valuation gap — 13 times earnings versus 24 to 43 times for named peers — remains the anchor. The risk is not in the businesses; it's in the insurance underwriting trend and the possibility that Abel's first major allocations (Alphabet, Taylor Morrison, OxyChem) are made at prices that compress future returns. But with $365 billion still on the balance sheet and buybacks resuming, the capital allocation engine is running again, and the stock remains a core compounding candidate at a discount to what the market charges for comparable scale and quality.

The gate to watch is insurance underwriting. If that continues to erode over the next two quarters, the thesis narrows to the investment portfolio and buybacks alone. If it stabilizes — which the float growth and rate environment should support — the valuation gap closes slowly in Berkshire's favor.